Miruvor
Sign up
The short answer

What studies of sleep hygiene and regular sleep schedule found

5papers on sleep hygiene and regular sleep schedule
1 (few people)person in 1 study testing sleep hygiene and regular sleep schedule alone
0randomised trials, the strongest kind of study

At a glance, by condition

Long COVID: C Might help, very uncertain

Based on the strongest evidence, studies with no comparison group (very low certainty), for pain.

1 outcome rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: Sleep hygiene and regular sleep schedule might help some people with long COVID, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 5 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. Sleep hygiene and regular sleep schedule · Long COVID is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. D
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

Long COVID

Pain1 study · 1 (few people) person took sleep hygiene and regular sleep schedule Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · three-year arc (few people)

Pain improved.

The evidence is very uncertain about the effect of sleep hygiene and regular sleep schedule on pain in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 1 study
  1. Corona With Lyme: A Long COVID Case Study. (2023)

    People in the study
    1 in the study
    Dose
    —
    Outcome
    severity and frequency of associated myalgias, headaches, and scalp allodynia
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Side effects

Side effects studies reported4 kinds
Side effects studies reported, and how many studies reported each
Side effectStudies that reported it
Anxiety or irritability1 study
Fatigue1 study
Headache1 study
Worse symptoms or a flare1 study

All papers

  1. Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) - a clinical audit.2013 · no comparison group · 138 in the study · 34 with outcome data
    Summary

    This is an audit from a UK private practice that treats ME/CFS. It covers 138 patients who took a blood test of how their white blood cells make energy (the ATP Profile). Every patient was advised a basic regime: a stone-age diet, enough good sleep, a standard package of nutritional supplements, and the right balance between work and rest. Extra steps were tailored to each person's test results, such as far-infrared saunas or selective chelation therapy. Only 34 patients had the test repeated, between 5 and 67 months later (30 months on average); the authors have no follow-up results for the other 104. Almost everything measured was a laboratory value, and the authors report that these values rose in the 30 patients who followed the regime but not in 4 who did not follow it. For how patients felt or functioned, the paper gives only individual stories and a general statement: one woman was able to resume work part time, another was back at work 4 days per week, and the authors write that for most patients the laboratory improvements were paralleled by clinical improvements, without measuring symptoms on any scale. They state that no patient reported any harm from the treatments. There was no randomised comparison, the authors could not confirm whether patients followed the advice, and the lead clinician's income comes from treating patients.

  2. 1171 Hypersomnia Secondary to Long Covid2024 · case report · 1 in the study
  3. Corona With Lyme: A Long COVID Case Study.2023 · case report · 1 in the study
    Summary

    This case report describes a previously healthy 26-year-old female medical student living in New York, NY, who developed long COVID after a presumed acute SARS-CoV-2 infection in March 2020, with a concurrent perceived early-disseminated Lyme disease infection. The three-year arc covers numerous trial-and-error treatments: a two-week regimen of doxycycline 100 mg twice a day, metformin escalation alongside diet modifications, graded compression stockings, breathing exercises, increases in caffeine and salt consumption with increased fluid intake, a horizontal cardio exercise program with rest periods, osteopathic manipulative treatment, cognitive behavioral therapy, sleep hygiene improvements, supplements (vitamin C, vitamin D, vitamin B12, B-complex, n-acetyl cysteine, turmeric extract), a two-dose Moderna mRNA COVID-19 vaccination course, and abortive headache therapies (Excedrin or Fioricet and prochlorperazine). The authors report a moderate reduction in cycle length and morning hypoglycemic symptoms with metformin, a moderate reduction in myalgias, headaches and scalp allodynia with osteopathic manipulative treatment, some relief of post-COVID headache, help with headache pain, orthostatic palpitations, fatigue and brain fog from abortive therapies plus caffeine, salt and fluid intake, moderate improvements in fatigue and brain fog in the first 24 hours after the first vaccine dose, moderate symptom alleviation from digital interventions, and small but recognizable differences in fatigue and cognition from sleep hygiene. No improvement in symptoms other than mild reduction in right shoulder pain followed the doxycycline regimen. Supplements provided no discernable benefit. The patient reports full recovery from long COVID with residual blurred vision and oligomenorrhea. Reported harms include worsening blurred vision, palpitations, heat intolerance and near-syncopal events; a moderate increase in fatigue and brain fog with a CGRP antagonist; fatigue exacerbation with traditional exercise rehabilitation; symptom re-exacerbations with compression stockings; and increased headache frequency and duration with n-acetyl cysteine. The abstract describes near-total remission.

  4. Sphenopalatine Ganglion Block for Postacute Sequelae SARS-CoV-2 Infection Headaches: A Case Report and Review of the Literature.2023 · case report · 1 in the study
    Summary

    This case report describes 1 patient in her 50s with postacute sequelae SARS-CoV-2 infection (PASC), or Long COVID, who was referred from the PASC clinic to the interventional pain clinic for persistent symptoms including headaches. There was no comparison group and no randomisation. The experimental treatment was a sphenopalatine ganglion block (SPGB) via an infrazygomatic approach, using a 2 mL solution consisting of 1mL of 10 mg/mL dexamethasone and 1 mL of 0.5% bupivacaine; the right side was treated first and then the left side. Background treatments included right and left stellate ganglion blocks, which temporarily relieved most symptoms for 2 weeks and completely resolved the anosmia and ageusia. After the right-sided SPGB, the patient reported more than an 80% improvement in headaches, blurry vision, and eye pain on the right, and significant improvement in sinus congestion, concentration, and short-term memory; the left-sided SPGB resulted in similar relief. The abstract reports an 80% improvement in symptoms after bilateral SPGB. To date, the patient still has significant relief with no refractory symptoms. Conservative therapies had minimal effects; LDN and mesenchymal stem cells gave short-term symptom relief; intravenous nicotinamide adenine dinucleotide therapy gave no alleviation in the last 2 months. No harms were described, and withdrawal from treatment was not reported. The patient was very pleased with the results of the injections into her nose. The authors state the single case is empirical until further case reports or series show similar benefits.

  5. Mildronate. Chronic fatigue syndrome2020 · case report · 1 in the study
    Summary

    The paper reports a case report of one 45-year-old woman with chronic fatigue syndrome and arterial hypertension who presented to a therapist. She received meldonium (Mildronat) orally 500 mg twice daily for 10 days, then a 14-day break and a repeat course. Background measures were regular physical exercise with a rehabilitation doctor, sleep-hygiene advice, and diet changes: limiting coffee and caffeine-containing products, alcohol, and salt to less than 5 g per day, and increasing plant foods and products containing potassium, calcium, magnesium. No comparison group was reported. Reported findings were increased work capacity, less fatigue, lower daily blood pressure variability, and lower resting heart rate from 83 to 73 уд./мин. after the repeat course. After the first course the patient reported improved state and mood; by the end of the repeat course headaches stopped, sleep normalized, she could perform duties more effectively, and family relations improved. Harms, side effects, worsening, and stopping treatment were not reported. The authors conclude the case may indicate effectiveness of meldonium together with regular physical training for CFS in patients with arterial hypertension; they do not state study limitations.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime